CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer

Although early-stage lung cancer has increased owing to the introduction of screening programs, high recurrence rate remains a critical concern. We aimed to explore biomarkers related to the prognosis of surgically resected non-small-cell lung cancer (NSCLC). In this retrospective study, we collecte...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2022-01, Vol.11 (2), p.341
Hauptverfasser:	Nam, Yunha, Choi, Chang-Min, Park, Young Soo, Jung, HyunA, Hwang, Hee Sang, Lee, Jae Cheol, Lee, Jung Wook, Lee, Jung Eun, Kang, Jung Hee, Jung, Byung Hun, Ji, Wonjun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Biomarkers Brain cancer Clinical medicine Lung cancer Medical prognosis Medical screening Metastasis Mortality Proteins Software Squamous cell carcinoma Statistical analysis Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!